Sensus Healthcare Analyst Ratings
Sensus Healthcare Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
02/10/2023 | 63.84% | Alliance Global Partners | $16.5 → $14.5 | Maintains | Buy |
11/04/2022 | 86.44% | Alliance Global Partners | $17.5 → $16.5 | Maintains | Buy |
05/06/2022 | 80.79% | HC Wainwright & Co. | $13 → $16 | Maintains | Buy |
03/03/2022 | 46.89% | HC Wainwright & Co. | $12 → $13 | Maintains | Buy |
02/14/2022 | 35.59% | HC Wainwright & Co. | $10 → $12 | Maintains | Buy |
12/02/2021 | 12.99% | HC Wainwright & Co. | $9 → $10 | Maintains | Buy |
11/05/2021 | 1.69% | HC Wainwright & Co. | $7 → $9 | Maintains | Buy |
08/06/2021 | -20.9% | HC Wainwright & Co. | $6 → $7 | Maintains | Buy |
03/01/2021 | -32.2% | HC Wainwright & Co. | $4 → $6 | Maintains | Buy |
02/26/2021 | -32.2% | Roth Capital | $4 → $6 | Maintains | Buy |
11/09/2020 | -54.8% | HC Wainwright & Co. | $5 → $4 | Maintains | Buy |
05/11/2020 | -66.1% | B. Riley Securities | $5.5 → $3 | Maintains | Neutral |
05/08/2020 | -43.5% | HC Wainwright & Co. | $8 → $5 | Reiterates | → Buy |
11/07/2019 | -37.85% | B. Riley Securities | $14 → $5.5 | Downgrades | Buy → Neutral |
09/19/2018 | 12.99% | Maxim Group | $9 → $10 | Maintains | Buy |
08/27/2018 | 58.19% | HC Wainwright & Co. | → $14 | Initiates Coverage On | → Buy |
08/01/2018 | 41.24% | Roth Capital | → $12.5 | Initiates Coverage On | → Buy |
日期 | 上/下行 | 分析師公司 | 价格目標變更 | 評級變更 | 上一頁/目前評分 |
---|---|---|---|---|---|
02/10/2023 | 63.84% | 聯盟全球夥伴 | 美元 → 14.5 美元 | 維護 | 購買 |
11/04/2022 | 86.44% | 聯盟全球夥伴 | 兩美元 → 16.5 美元 | 維護 | 購買 |
2022 年 6 月 5 日 | 80.79% | HC 溫賴特 & 有限公司. | 十三美元 → 十六美元 | 維護 | 購買 |
03/03/2022 | 46.89% | HC 溫賴特 & 有限公司. | 十二元 → 十三美元 | 維護 | 購買 |
02/14/2022 | 35.59% | HC 溫賴特 & 有限公司. | 十元 → 十二美元 | 維護 | 購買 |
12/02/2021 | 12.99% | HC 溫賴特 & 有限公司. | 九元 → 十美元 | 維護 | 購買 |
2021 年 5 月 11 日 | 1.69% | HC 溫賴特 & 有限公司. | 7 美元 → 9 美元 | 維護 | 購買 |
2021 年 6 月 8 日 | -20.9% | HC 溫賴特 & 有限公司. | 6 美元 → 7 美元 | 維護 | 購買 |
03/01/2021 | -32.2% | HC 溫賴特 & 有限公司. | 4 美元 → 6 美元 | 維護 | 購買 |
02/26/2021 | -32.2% | 羅斯資本 | 4 美元 → 6 美元 | 維護 | 購買 |
11/09/2020 | -54.8% | HC 溫賴特 & 有限公司. | 5 美元 → 4 美元 | 維護 | 購買 |
05/11/2020 | -66.1% | B. 萊利證券 | $5.5 美元 → 3 美元 | 維護 | 中性 |
2020 年 5 月 8 日 | -43.5% | HC 溫賴特 & 有限公司. | 8 美元 → 5 美元 | 重申 | → 購買 |
11/07/2019 | -37.85% | B. 萊利證券 | 十四美元 → 5.5 美元 | 降級 | 購買 → 中性 |
09/19/2018 | 12.99% | 美心集團 | 九元 → 十美元 | 維護 | 購買 |
2018 年 8 月 27 日 | 58.19% | HC 溫賴特 & 有限公司. | → 十四美元 | 啟動覆蓋範圍 | → 購買 |
2018 年 1 月 8 日 | 41.24% | 羅斯資本 | → 十二美元 | 啟動覆蓋範圍 | → 購買 |
What is the target price for Sensus Healthcare (SRTS)?
盛思醫療 (SRTS) 的目標價格是多少?
The latest price target for Sensus Healthcare (NASDAQ: SRTS) was reported by Alliance Global Partners on February 10, 2023. The analyst firm set a price target for $14.50 expecting SRTS to rise to within 12 months (a possible 63.84% upside). 5 analyst firms have reported ratings in the last year.
聯盟全球合作夥伴於 2023 年 2 月 10 日報導了 Sensus 醫療(納斯達克股票代碼:SRTS)的最新價格目標。該分析師公司設定了 14.50 美元的價格目標,預計 SRTS 將在 12 個月內上升(可能為 63.84% 上漲)。5 分析師公司在去年報告了評級。
What is the most recent analyst rating for Sensus Healthcare (SRTS)?
Sensus 醫療 (SRTS) 的最新分析師評級為何?
The latest analyst rating for Sensus Healthcare (NASDAQ: SRTS) was provided by Alliance Global Partners, and Sensus Healthcare maintained their buy rating.
Sensus 醫療保健(納斯達克股票代碼:SRTS)的最新分析師評級由聯盟全球合作夥伴提供,而 Sensus 醫療保持其購買評級。
When is the next analyst rating going to be posted or updated for Sensus Healthcare (SRTS)?
Sensus 醫療(SRTS)的下一個分析師評級何時公佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sensus Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sensus Healthcare was filed on February 10, 2023 so you should expect the next rating to be made available sometime around February 10, 2024.
分析師在進行了廣泛的研究後獲得股票評級,其中包括通過公共財務報表,與 Sensus Healthcare 的高管和客戶交談以及收聽盈利電話會議。大多數分析師每三個月這樣做一次,因此您應該每年每家公司獲得 4 個評級。Sensus 醫療保健的最後一個評級提交了 2023 年 2 月 10 日,因此您應該期望下一個評級將在 2024 年 2 月 10 日左右的某個時候提供。
Is the Analyst Rating Sensus Healthcare (SRTS) correct?
分析師評級 Sensus 醫療保健(SRTS)是否正確?
While ratings are subjective and will change, the latest Sensus Healthcare (SRTS) rating was a maintained with a price target of $16.50 to $14.50. The current price Sensus Healthcare (SRTS) is trading at is $8.85, which is out of the analyst's predicted range.
儘管評級是主觀的並且會發生變化,但最新的 Sensus 醫療保健(SRTS)評級維持,目標價格為 16.50 美元至 14.50 美元。目前的價格 Sensus 醫療保健(SRTS)的交易價格為 8.85 美元,這是超出了分析師的預測範圍。
譯文內容由第三人軟體翻譯。